Poland· PL-100077318
Curatoderm
A tacalcitol product containing tacalcitolum, registered in Poland by Almirall Hermal GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tacalcitol is registered in 8 of 19 countries.
Countries holding a registration under ATC D05AX04 (tacalcitol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Tacalcitol · ATC D05AX04
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Japan
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Tacalcitolum
- Manufacturer
- Almirall Hermal GmbH
- Country
- Poland (PL)
- ATC code
- D05AX04
- ATC class
- Tacalcitol
- Defined daily dose
- 4 mcg, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990732319
- gtin05909990732326
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacalcitol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCuratoderm 4micrograms/g lotionAlmirall Ltd
- SwitzerlandCuratoderm
- BelgiumCuratoderm 4 µg/gAlmirall Hermal
- GermanyCuratodermAlmirall Hermal Gmbh
- CzechiaCURATODERMAlmirall Hermal GmbH, Reinbek
- SpainBONALFA 4 MICROGRAMOS/G POMADAIsdin S.A.
- ItalyVELLUTAN*ung derm 20 g 4 mcg/gABIOGEN PHARMA SpA
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Curatoderm
- Belgium · Curatoderm
- Czechia · Curatoderm
- Germany · Curatoderm
- United Kingdom (Northern Ireland) · Curatoderm
- Hungary · Curatoderm
- Luxembourg · Curatoderm
- Slovakia · Curatoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/16e10b4f-2180-4fc9-9a70-f69adec3fc44 GET /v1/drugs/16e10b4f-2180-4fc9-9a70-f69adec3fc44?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "4,17 mg/g",
"packaging": "05909990732319 ¦ Rp ¦ 11646\n1 op. 20 g\n05909990732326 ¦ Rp ¦ 11647\n1 op. 60 g",
"substance": "Tacalcitolum monohydricum 0,000417 g/100 g",
"common_name": "Tacalcitolum",
"pl_product_id": "100077318",
"pozwolenie_nr": "07323",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about tacalcitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.